AI-Driven Drug Discovery Becomes Pharma's Next Big Bet

Artificial intelligence is poised to revolutionize drug discovery, potentially cutting preclinical R&D costs and timelines by 70%, with its ultimate success depending on delivering safe and effective medicines.